Related references
Note: Only part of the references are listed.Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome
Lin Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Abnormal Immune Regulation and Low-Grade Inflammation in IBS: Does One Size Fit All?
Max Schmulson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome
Cesare Cremon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Fracture-Associated Hospitalizations in Patients with Inflammatory Bowel Disease
Ashwin N. Ananthakrishnan et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach
Peter R. Gibson et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women
Jonathan D. Adachi et al.
MAYO CLINIC PROCEEDINGS (2010)
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study
George Ioannidis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Vijay K. Yadav et al.
CELL (2008)
Comorbidity in irritable bowel syndrome
William E. Whitehead et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Medical progress: Celiac disease
Peter H. R. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Use of antidepressants and rates of hip bone loss in older women
Susan J. Diem et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men
Elizabeth M. Haney et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Immune activation in patients with irritable bowel syndrome
Tobias Liebregts et al.
GASTROENTEROLOGY (2007)
Effect of selective serotonin reuptake inhibitors on the risk of fracture
J. Brent Richards et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
The serotonin signaling system: From basic understanding to drug development-for functional GI disorders
Michael D. Gershon et al.
GASTROENTEROLOGY (2007)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Preventing osteoporosis-related fractures: An overview
M Gass et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease
M Bernstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Use of psychopharmacological agents for functional gastrointestinal disorders
RE Clouse et al.
GUT (2005)
Alcohol intake as a risk factor for fracture
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Smoking and fracture risk: a meta-analysis
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
A meta-analysis of previous fracture and subsequent fracture risk
JA Kanis et al.
BONE (2004)
Positive association between 25-hydroxy, vitamin D levels and bone mineral density: A population-based study of younger and older adults
HA Bischoff-Ferrari et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Use of oral corticosteroids and risk of fractures
TP Van Staa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
